These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29300929)

  • 41. XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells.
    Allensworth JL; Aird KM; Aldrich AJ; Batinic-Haberle I; Devi GR
    Mol Cancer Ther; 2012 Jul; 11(7):1518-27. PubMed ID: 22508521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production.
    Kim WS; Lee KS; Kim JH; Kim CK; Lee G; Choe J; Won MH; Kim TH; Jeoung D; Lee H; Kim JY; Ae Jeong M; Ha KS; Kwon YG; Kim YM
    Free Radic Biol Med; 2017 Nov; 112():567-577. PubMed ID: 28888620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bakuchiol sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
    Park MH; Kim JH; Chung YH; Lee SH
    Biochem Biophys Res Commun; 2016 Apr; 473(2):586-92. PubMed ID: 27033605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway.
    Naumann I; Kappler R; von Schweinitz D; Debatin KM; Fulda S
    Clin Cancer Res; 2011 May; 17(10):3204-18. PubMed ID: 21459798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
    Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
    Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
    Kauntz H; Bousserouel S; Gossé F; Raul F
    Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice.
    Xu ZF; Sun XK; Lan Y; Han C; Zhang YD; Chen G
    Biomed Pharmacother; 2017 Nov; 95():1607-1618. PubMed ID: 28950661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
    Jayasooriya RG; Choi YH; Hyun JW; Kim GY
    Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2.
    Yang ES; Woo SM; Choi KS; Kwon TK
    Exp Cell Res; 2011 Nov; 317(18):2592-601. PubMed ID: 21854768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma.
    Gu LQ; Li FY; Zhao L; Liu Y; Zang XX; Wang TX; Chen HP; Ning G; Zhao YJ
    Thyroid; 2009 Apr; 19(4):347-54. PubMed ID: 19355825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Casticin, a flavonoid, potentiates TRAIL-induced apoptosis through modulation of anti-apoptotic proteins and death receptor 5 in colon cancer cells.
    Tang SY; Zhong MZ; Yuan GJ; Hou SP; Yin LL; Jiang H; Yu ZΥ
    Oncol Rep; 2013 Feb; 29(2):474-80. PubMed ID: 23135489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells.
    Park C; Jin CY; Hwang HJ; Kim GY; Jung JH; Kim WJ; Yoo YH; Choi YH
    Toxicol In Vitro; 2012 Feb; 26(1):86-93. PubMed ID: 22079975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.
    Festa M; Petrella A; Alfano S; Parente L
    Int J Cancer; 2009 Jun; 124(11):2728-36. PubMed ID: 19230027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
    Qiu W; Yang Z; Fan Y; Zheng Q
    Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AY4, an agonistic anti-death receptor 4 MAB, induces apoptotic cell death in anaplastic thyroid cancer cells via downregulation of Bcl-xL with reactive oxygen species generation.
    Lee BS; Cha HY; Shin YS; Kim YS; Kim CH
    Endocr Relat Cancer; 2013 Jun; 20(3):283-91. PubMed ID: 23429749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest.
    Kang S; Kang D; Bakhtiar Ul Islam SM; Je S; Kim JH; Song JJ
    Cell Signal; 2015 Jun; 27(6):1214-24. PubMed ID: 25748050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis.
    Koschny R; Holland H; Sykora J; Erdal H; Krupp W; Bauer M; Bockmuehl U; Ahnert P; Meixensberger J; Stremmel W; Walczak H; Ganten TM
    J Neurooncol; 2010 Apr; 97(2):171-85. PubMed ID: 19768634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis.
    Ehrenschwender M; Bittner S; Seibold K; Wajant H
    Cell Death Dis; 2014 Dec; 5(12):e1570. PubMed ID: 25501831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.
    Saini S; Sripada L; Tulla K; Qiao G; Kunda N; Maker AV; Prabhakar BS
    Endocr Relat Cancer; 2019 Jun; 26(6):551-563. PubMed ID: 30999276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.